Availability of the Q2 2022 Memorandum for modelling purposes

Availability of the Q2 2022 Memorandum for modelling purposes Paris, France – June 24, 2022 – Sanofi announced today that its Q2 2022 Memorandum for modelling purposes is available on the “Investors” page of the company’s website: As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group’s quarterly … Read more